arrow
J

Jan J. Molenaar

princess maxima center for pediatric oncology
H指数:51
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CAR T cell-induced interferon gamma enhances MHC class I expression and sensitizes neuroblastoma to TCR-engineered T cell therapy

CAR T细胞诱导的干扰素γ增强MHC I类分子表达并使神经母细胞瘤对TCR工程化T细胞治疗更敏感

2026-11-100
OAAI
Current Treatment Strategies for First Relapse of High-Risk Neuroblastoma

高危神经母细胞瘤首次复发的当前治疗策略

2026-01-290
OAAI
Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk

与最初诊断为非高危神经母细胞瘤且具有高危临床病程相关的分子特征

Cancers
IF4.4
2026-01-170
OAAI
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM

弥漫性中线胶质瘤的分子特征与临床特征:基于儿科精准肿瘤学登记系统INFORM的研究

2025-10-110
OA
Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function

抗B7H3 CAR-T构建体的功能亲合力预测触发效应功能的抗原密度阈值

2025-08-050
OA
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration

儿童及青少年周期蛋白依赖性激酶抑制剂药物开发儿科策略论坛ACCELERATE,与欧洲药品管理局合作,并邀请美国食品药品监督管理局参与。

2025-07-110
PRE
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression

染色体17的获得是神经母细胞瘤中的一种早期遗传异常,其中PPM1D正作为一个强候选癌基因出现,驱动肿瘤进展。

2025-06-040
PRE
Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER' (vol 175, pg 311, 2022)

将儿科精准肿瘤学纳入临床实践:儿童癌症个体化治疗计划'iTHER'(卷175,页311,2022年)

2025-05-010
OAAI
Complex structural variation is prevalent and highly pathogenic in pediatric solid tumors
2024-11-010
OAAI
Whole genome sequencing can reproduce all standard-of-care diagnostics for childhood cancer: Results from two national systems
2024-09-050
PRE
ITCC-P4, a preclinical proof-of-concept drug testing platform as a tool for pharmacological screening in pediatric tumor models

ITCC-P4,一个临床前概念验证药物测试平台,作为儿科肿瘤模型药理筛选的工具

2024-03-220
PRE